Press Release: Ardent Health Announces Second Quarter 2026 Results Conference Call and Webcast Date

Dow Jones
07/17
BRENTWOOD, Tenn.--(BUSINESS WIRE)--July 17, 2026-- 

Ardent Health $(ARDT)$, a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its second quarter 2026 results after the market closes on Tuesday, August 4, 2026. A conference call will be held the following day, Wednesday, August 5, 2026, at 10 a.m. ET to review the Company's financial results and conduct a question-and-answer session.

A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register, download, and install any necessary audio software.

To participate in the live teleconference:

 
North America Toll-Free:           1-888-596-4144 
International Toll:                1-646-968-2525 
Access Code:                       4437657 
 

To listen to a replay of the teleconference, which will be available through August 19, 2026:

 
North America Toll-Free:           1-800-770-2030 
International Toll:                1-647-362-9199 
Access Code:                       4437657 
 

About Ardent Health

Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. The Company delivers care through its subsidiaries, which include 30 acute care hospitals and more than 280 sites of care with over 2,000 employed and affiliated providers across six states. Anchored by a shared operating model and a commitment to investing in innovative services and technologies that improve quality, access and experience, we are committed to delivering strong clinical outcomes and improving the health of the patients and communities we serve.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260717066241/en/

 
    CONTACT:    Investor contact: 

Dave Styblo, CFA

investor.relations@ardenthealth.com

(615) 296-3016

Media contact:

Rebecca Kirkham

rebecca.kirkham@ardenthealth.com

(615) 296-3000

 
 

(END) Dow Jones Newswires

July 17, 2026 08:01 ET

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10